Track record · closed signal

Merck & Co., Inc. (MRK) — closed signal from September 10, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on December 9, 2025.

Predicted vs. what happened

MRK price · publication thesis → realized outcomesplit-adjusted
$82.70 Published $89.32 Target $96.07 Window close $104.94 Peak
$80.01 – $80.97Entry zone — fair-value band
$82.70Published — price the day we called it
$89.32Target — the price the thesis aimed for
$104.94Peak — highest point inside the window, not a realized return
$96.07Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 63 days.

Peak price
$104.94
peak on November 25, 2025 — not a realized return
Peak gain
+26.9%
peak, from the publication price
Window close
$96.07
end-of-window price, context only
Days to target
63
Window
September 10, 2025 – December 9, 2025

The thesis — published September 10, 2025

Predicted growth
+10%
over the measurement window
Target price
$89.32
the price the thesis aimed for
Entry zone
$80.01 – $80.97
the fair-value band we waited for
Price at publication
$82.70
published September 10, 2025
Confidence
67%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Merck looks set for a short-term recovery as recent price action calms and buyer interest improves. Investor mood is decent, but government policy news is creating noise. Talk of possible White House limits on China-invented medicines adds uncertainty, yet Merck's broad drug lineup and steady cash help limit downside. With easing interest rates, a 0-3 month move back toward typical price levels seems reasonable if risk is managed well.

Primary drivers

  • The stock pulled back, and signs suggest more buyers may now be stepping in
  • Strong, steady cash generation helps the business hold up in rough times
  • Government policy headlines, especially on China drugs, could pressure shares
  • Falling interest rates can make steady, dependable companies more appealing

How it played out

MRK: target reached in 63 days

On 2025-09-10, Lyra published a short-term MRK thesis at 82.70 with expected growth of 10%. The thesis pointed to calmer recent price action, improving buyer interest, steady cash generation, possible pressure from government policy headlines on China-invented medicines, and lower interest rates making dependable companies more appealing.

Inside the 2025-09-10 to 2025-12-09 window, MRK reached the 89.32 target in 63 days. The peak was 104.94 on 2025-11-25, a 26.9% gain. It ended at 96.07. The published thesis played out, because the stock reached the target and stayed above it at the end.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All MRK signals